Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa

NANot yet recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Placenta Previa
Interventions
DRUG

Topical tranexamic acid

Topical tranexamic acid will be applied after placental delivery on the placental bed for 5 minutes by using a sterile towel soaked with 2g tranexamic acid (Kapron, Amoun, Cairo, Egypt) (4 ampules 500ug) diluted in 100ml of sodium chloride 0.9%

DRUG

Intravenous tranexamic acid

Intravenous tranexamic acid will be given in the form of an IV infusion of 1g of tranexamic acid (2 ampules 500ug) diluted with 20 ml of 5% glucose administered just after delivery of the fetus.

All Listed Sponsors
lead

Cairo University

OTHER

NCT06515535 - Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa | Biotech Hunter | Biotech Hunter